CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.
Qin H, Dong Z, Wang X, Cheng WA, Wen F, Xue W, Sun H, Walter M, Wei G, Smith DL, Sun X, Fei F, Xie J, Panagopoulou TI, Chen CW, Song JY, Aldoss I, Kayembe C, Sarno L, Müschen M, Inghirami GG, Forman SJ, Kwak LW.
Qin H, et al. Among authors: forman sj.
Sci Transl Med. 2019 Sep 25;11(511):eaaw9414. doi: 10.1126/scitranslmed.aaw9414.
Sci Transl Med. 2019.
PMID: 31554741
Free PMC article.